Healthcare services company Chemed Corporation (NYSE:CHE) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 9.8% year on year to $646.9 million. Its non-GAAP profit of $5.63 per ...
Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The second quarter ...
Hosted on MSN
CHE Q1 Earnings Call: Acquisition-Driven Growth and Medicare Cap Strategy Shape Outlook
Healthcare services company Chemed Corporation (NYSE:CHE) in Q1 CY2025, with sales up 9.8% year on year to $646.9 million. Its non-GAAP profit of $5.63 per share was 1.5% above analysts’ consensus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback